Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMedicx Fund Regulatory News (MXF)

  • There is currently no data for MXF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Primary Health Properties Plc

13 Mar 2019 12:28

RNS Number : 7708S
Smith & Williamson Investment Mngmt
13 March 2019
 

 FORM 8.3

 

DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Smith and Williamson Investment Management

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Primary Health Properties Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

12/03/2019

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes

Medicx Fund Limited

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Ordinary GBP0.125

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

13,603,710

1.72%

(2) Cash-settled derivatives:

 

N/A

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

N/A

 

TOTAL:

13,603,710

1.72%

 

* The change in holding includes a movement of 4,740 shares into our Discretionary holding.

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit (£)

ORD GBP0.125

Purchase

1,530

1.237259

ORD GBP0.125

Sale

1,682

1.23872

 

 

 (b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

N/A

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

N/A

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

13/03/2019

Contact name:

Bola Ogundeji

Compliance Officer

Smith & Williamson

Telephone number:

020 7131 4314

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETJJMTTMBTBBIL
Date   Source Headline
30th Nov 20174:56 pmRNSNotification of major holdings
28th Nov 201711:45 amRNSNotification of major holdings
24th Nov 20174:20 pmRNSScrip Calculation Price for December 2017 Dividend
21st Nov 20175:05 pmRNSNotification of major holdings
21st Nov 20173:01 pmRNSPublication of Circular - Scrip Dividend Scheme
20th Nov 20174:22 pmRNSNotification of major holdings
20th Nov 20177:00 amRNSAcquisition of a new primary healthcare centre
16th Nov 20173:42 pmRNSDisposal of five properties
1st Nov 20172:14 pmRNSNotice of dividend
16th Oct 20174:16 pmRNSNotification of major holding
13th Oct 20172:49 pmRNSNotification of major holding TR1
2nd Oct 20171:04 pmRNSAllotment of scrip shares to Directors
27th Sep 201711:06 amRNSNotification of major holdings
27th Sep 201710:18 amRNSDirector Declaration
18th Sep 20173:54 pmRNSSecurities allotted from Block Listing
12th Sep 20175:25 pmRNSExtraordinary General Meeting results
12th Sep 20179:01 amRNSScrip Dividend Declaration
8th Sep 20173:30 pmRNSNotification of major interest in shares
24th Aug 20176:17 pmRNSScrip Dividend Declaration
23rd Aug 20173:04 pmRNSPublication of Circular - Scrip Dividend Scheme
18th Aug 20178:48 amRNSPublication of Circular
11th Aug 201712:42 pmRNSBlock listing application
10th Aug 20172:43 pmRNSQuarterly NAV announcement and business update
28th Jul 20172:46 pmRNSBoard changes
28th Jul 20172:45 pmRNSNotice of dividend
26th Jul 20172:10 pmRNS£27.5 m private placement of loan notes
3rd Jul 20174:02 pmRNSAllotment of scrip shares to Directors
15th Jun 20175:08 pmRNSIssue of ordinary shares
14th Jun 201710:09 amRNSScrip Dividend Declaration
30th May 201711:50 amRNSPurchase of Shares by PDMR
26th May 20177:00 amRNSHalf-year Report
25th May 20173:11 pmRNSScrip Calculation Price for the June 2017 Dividend
25th May 20173:09 pmRNSPublication of Circular - Scrip Dividend Scheme
24th May 201710:00 amRNSAcquisition - primary healthcare centre in Ireland
18th May 20174:15 pmRNSIssue of ordinary shares
9th May 201710:13 amRNSIssue of ordinary shares
3rd May 20174:04 pmRNSIssue of ordinary shares
2nd May 20172:29 pmRNSIssue of ordinary shares
2nd May 20178:58 amRNSNotice of dividend
26th Apr 20175:08 pmRNSIssue of ordinary shares
25th Apr 20173:30 pmRNSIssue of ordinary shares
13th Apr 201710:30 amRNSIssue of ordinary shares
12th Apr 20171:40 pmRNSIssue of ordinary shares
4th Apr 20174:32 pmRNSIssue of ordinary shares
3rd Apr 201711:26 amRNSAllotment of scrip shares and total voting rights
3rd Apr 201711:25 amRNSDirector Declaration
30th Mar 20173:55 pmRNSAcquisition of two new primary healthcare centres
21st Mar 20173:00 pmRNSIssue of ordinary shares
17th Mar 20177:00 amRNSSecurities allotted from Block Listing
15th Mar 20175:58 pmRNSREIT Conversion

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.